ATG2A and neurodegenerative disease: Strikingly, mutations of two of the residues at the same position in WIPI4 and Hsv2, which have been identified in patients with the neurodegenerative disease BPAN, prevent the interaction between Hsv2/WIPI4 and Atg2/ATG2A [16].